Absorption, distribution, metabolism, excretion, and pharmacokinetics of remibrutinib, an oral, highly selective Bruton tyrosine kinase inhibitor, in healthy participants at steady state

Drug Metabolism and Disposition · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles